Navigation Links
LES in Medical Technology

Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier

Pharmacyclics to maintain all US Rights Conference Call to discuss the company's third quarter financial results is scheduled for April 23, 2009 at 11:00 a.m. EDT (8:00 a.m. PDT). SUNNYVALE, Calif., April 17 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC ) today announced...

PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy

... Muscular Dystrophy Association ( www.mdausa.org ), Parent Project Muscular Dystrophy ( www.parentprojectmd.org ) and the Association Francaise contre les Myopathies ( www.afm-france.org ). About Ataluren (PTC124(TM)) Ataluren is an orally delivered, investigational new drug discovered by PTC Th...

Isogen Launches Major New Facility to Address Global Biopharma Demand

... will help our customers address major industry dynamics that are reshaping the face and complexity of sterile clinical trials materials supply," said les Edwards, CEO, Isogen. "Regulators in the U.S. and Europe increasingly require sterile clinical trials supplies to be manufactured in accordance with c...

Takeda's Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed

..., does not close properly. This valve opens to allow food and liquids to enter the stomach and closes to keep acid and food in the stomach. When the les does not close as tightly as it should, or relaxes too often, it can allow stomach contents to enter the esophagus repeatedly. The stomach is better e...

Hope for Progeria - Successfully Validated on Mice, a Treatment Could Soon be Tested on Children

...jected clinical protocol, this work - published in the review Nature Medicine - has received the financial backing of the Association Francaise contre les Myopathies (Muscular Dystrophy Association) thanks to French Telethon donations. The treatment recently validated in mice is based on a combination ...

Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers

...ease toxicity," Pui said. "That way, we don't over treat low-risk patients or under treat high-risk patients." Other authors of this paper include les Robison (St. Jude) and A. Thomas Look (Dana-Farber Cancer Institute and Harvard Medical School, Boston). This work was supported in part by grants...

Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)

...gress. This is our second Phase 2 study of PS433540 in hypertensive patients to provide key indications of the compound's therapeutic potential," said les Browne, Ph.D., President and Chief Executive Officer of Pharmacopeia. "We look forward to the completion of this study by the end of 2008 as well as t...

Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA)

...development timeline, but we have now completed enrollment in the study with the expectation of reporting results in the second quarter of 2008," said les Browne, Ph.D., Pharmacopeia's President and Chief Executive Officer. "As this is the first PS433540 study to include hypertensive patients, we are ple...

Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development

...engthens Pharmacopeia's internal pipeline with a wholly-owned development candidate with the potential to address significant therapeutic needs," said les Browne, Ph.D., President and Chief Executive Officer of Pharmacopeia. "We believe this nomination is a testament to our drug discovery expertise which...

AHF Seeks White House Clarification After Press Room Flap Over CDC's HIV Numbers

...ation from the White House regarding a press briefing late last week during which Deputy Press Secretary Dana Perino had a curt exchange with reporter les Kingsolving over questions he tried to pose regarding the Centers for Disease Control (CDC) and its latest US HIV data. Kingsolving, from the ultra-co...

Pharmacopeia Announces Third Quarter 2007 Financial Results

...recent clinical progress with PS433540 as well as the in-licensing of our new SARM program has significantly enhanced Pharmacopeia's pipeline," stated les Browne, Ph.D., Pharmacopeia's President and Chief Executive Officer. "We now have two of our own programs in clinical development as well as two partn...

Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate

...ring-Plough as a result of this trial initiation. "The Schering-Plough collaboration continues to yield very attractive therapeutic candidates," said les Browne, Ph.D., President and Chief Executive Officer of Pharmacopeia. "This compound is the third drug candidate resulting from the collaboration that...

Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration

...ase inhibitors could be effective in a range of inflammatory diseases including psoriasis, rheumatoid arthritis, and inflammatory bowel disease," said les Browne, Ph.D., President and Chief Executive Officer of Pharmacopeia. "Psoriasis is an important indication to evaluate in order to rapidly achieve pr...

Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA)

...iated this important Phase 2a concept validation study of PS433540 approximately six months ahead of our original clinical development timeline," said les Browne, Ph.D., President and Chief Executive Officer of Pharmacopeia. "The goal of this study is to prove that PS433540 lowers blood pressure in hyper...
Other Tags
(Date:10/15/2014)... has admitted Johannes Gutenberg University Mainz (JGU) as ... hub continues to maintain a significant nationwide standing ... "The acceptance of Johannes Gutenberg University Mainz as ... milestone in the national and international competition for ... of Rhineland-Palatinate can be proud that Mainz University ...
(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
(Date:10/14/2014)... 2014)—It,s been millions of years since T. rex ... by Ohio University scientists is breathing life back into ... dinosaur snouts. The research has important implications for how ... to enhance the sense of smell and cool their ... Ohio University doctoral student Jason Bourke, lead author of ...
Breaking Biology News(10 mins):Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
(Date:10/22/2014)... Losing Weight Your Body’s Way , In a world ... face, it certainly can be difficult to choose the right ... favor by doing it the healthy way? Set aside the ... your body, exercise regularly, and choose foods with the most ... you need to exercise more and eat less. Despite the ...
(Date:10/22/2014)... 22, 2014 Lintelus, Inc., an event ... President of Sales, will be speaking on the subject ... Expo on October 28, at the Holiday Inn in ... booth as well as a Tech Demo at 12:45pm, ... create a more engaging event experience. , The Annual ...
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately held ... infections, microbial biofilms, and chronic wounds, announced that Dr. ... , Dr. Sinskey is a Professor ... of Technology, or MIT. He has been a member ... holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter , ... in vitro fertilization (IVF) are only about half as likely ... reproduction technique, new research indicates, and the racial disparity persists ... about 31 percent of white patients became pregnant after IVF, ... more than 4,000 IVF cycles over two years to tease ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... may lead to increased blood pressure, according to a new ... in blood pressure for young adult women or for teenagers, ... drank lightly or moderately, their risk of high blood pressure ... parallels studies in older adult men and women," said lead ...
Breaking Medicine News(10 mins):Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4
Other Contents